Search
for
Sort by
Research 451–480 of 1000+
- Tricoscopia en la alopecia areata
- Regulatory T‐cells in alopecia areata
- Treatment of Alopecia Areata with Simvastatin/Ezetimibe
- Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata
- Alopecia Areata: An Update on Treatment Options for Children
- Current Treatments for Alopecia Areata
- Treatment of alopecia areata with squaric acid dibutylester
- Comparison of Zn, Cu, and Fe Content in Hair and Serum in Alopecia Areata Patients with Normal Group
- Dermoscopic findings of alopecia areata in dark skinned individuals: An analysis of 116 cases
- Combination Therapy with Cyclosporine and Psoralen Plus Ultraviolet A in the Patients with Severe Alopecia Areata: A Retrospective Study with a Self-Controlled Design
- Late‐onset alopecia areata: A retrospective study of 73 patients from Taiwan
- Serum vitamin B12, folate, ferritin, and iron levels in turkish patients with alopecia areata
- A case of widespread non‐pigmented hair regrowth in diffuse alopecia areata
- Periocular pigmentation associated with use of travoprost for the treatment of alopecia areata of the eyelashes
- Phenotypic Analysis of T-Cells in Extensive Alopecia Areata Scalp Suggests Partial Tolerance
- High-dose steroid pulse therapy for the treatment of severe alopecia areata.
- Alopecia Areata Associated with Myasthenia Gravis and Thymoma: A Case of Alopecia with Marked Improvement Following Thymectomy and High Level Prednisolone Administration
- The treatment of alopecia areata.
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care*
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Integrative analysis of rare copy number variants and gene expression data in alopecia areata implicates an aetiological role for autophagy
- Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series
- Minoxidil for patchy alopecia areata: systematic review and meta‐analysis